UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)



ý	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED ~~DECEMBER~~MARCH 31, ~~2014~~2015



¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 333-83780

SRA International, Inc.

(Exact name of Registrant as Specified in its Charter)



Virginia		54-1013306
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)

4300 Fair Lakes Court, Fairfax, Virginia		22033
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (703) 803-1500

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ¨ Yes ý No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ý No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer ý Smaller Reporting Company ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.). Yes ¨ No ý

As of ~~February~~May 65, 2015, there were 1,000 shares outstanding of the registrant’s common stock.

SRA INTERNATIONAL, INC.

QUARTERLY REPORT ON FORM 10-Q FOR THE THREE AND ~~SIX~~NINE MONTHS ENDED ~~DECEMBER~~MARCH 31, ~~2014~~2015

TABLE OF CONTENTS

		Page
Part I.	FINANCIAL INFORMATION
Item 1.	Condensed Consolidated Balance Sheets – June 30, 2014 and ~~December~~March 31, ~~2014~~2015 (Unaudited)	2
	Condensed Consolidated Statements of Operations (Unaudited) – Three and six months ended December 31, 2013 and 2014	3
	Condensed Consolidated Statements of Operations (Unaudited) – Three and nine months ended March 31, 2014 and 2015	3
	Condensed Consolidated Statements of Comprehensive Loss (Unaudited) – Three and six months ended December 31, 2013 and 2014	4
	Condensed Consolidated Statements of Comprehensive Loss (Unaudited) – Three and nine months ended March 31, 2014 and 2015	4
	Condensed Consolidated Statements of Cash Flows (Unaudited) – Six months ended December 31, 2013 and 2014	5
	Condensed Consolidated Statements of Cash Flows (Unaudited) – Nine months ended March 31, 2014 and 2015	5
	Notes to Condensed Consolidated Financial Statements (Unaudited)	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1516
	Overview	1516
	Forward-Looking Statements	1516
	Non-GAAP Financial Measures	1718
	Business Environment and Outlook	1718
	Key Metrics	2021
	Seasonality	2021
	Summary of Financial Results	2223
	Items Affecting the Comparability of Our Operating Results	2223
	Results of Operations	2425
	Liquidity and Capital Resources	2728
	Off-Balance Sheet Arrangements	2930
	Description of Critical Accounting Policies and Estimates	2930
	Recent Accounting Pronouncements	2930
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	2930
Item 4.	Controls and Procedures	3031
Part II.	OTHER INFORMATION
Item 1.	Legal Proceedings	3132
Item 1A.	Risk Factors	3132
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	3132
Item 3.	Defaults Upon Senior Securities	3132
Item 4.	Mine Safety Disclosures	3132
Item 5.	Other Information	3132
Item 6.	Exhibits	3233
Signatures		3334

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

SRA INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

	June 30, 2014			~~December~~March 31, ~~2014~~2015
				(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	108,840		$	95143,~~830~~452
Restricted cash	1,619			681
Accounts receivable, net	217,677			~~225~~212,~~739~~659
Prepaid expenses and other	5,643			79,~~697~~794
Total current assets	333,779			~~329~~366,~~947~~586
Property and equipment, net	18,925			1817,~~484~~399
Goodwill	783,604			783,604
Trade names	150,200			150,200
Identified intangibles, net	253,916			~~224~~210,~~900~~680
Other long-term assets	35,632			3230,~~151~~709
Total assets	$	1,576,056		$	1,~~539~~559,~~286~~178
LIABILITIES AND STOCKHOLDER'S EQUITY
Current liabilities:
Current portion of long-term debt	$	22,000		$	~~30,000~~—
Accounts payable and accrued expenses	136,626			~~124~~148,~~586~~845
Accrued payroll and employee benefits	83,017			8276,~~271~~428
Billings in excess of revenue recognized	10,801			98,~~415~~353
Deferred income taxes	5,355			14,~~376~~228
Total current liabilities	257,799			~~247~~237,~~648~~854
Long-term debt	1,047,927			1,~~029~~059,~~639~~863
Deferred income taxes	104,941			~~108~~105,~~037~~255
Other long-term liabilities	24,741			1720,~~689~~721
Total liabilities	1,435,408			1,~~403~~423,~~013~~693
Commitments and contingencies
Stockholder's equity:
Common stock, par value $0.01 per share; 1,000 shares authorized, issued and outstanding as of June 30, 2014 and December 31, 2014	—			—
Common stock, par value $0.01 per share; 1,000 shares authorized, issued and outstanding as of June 30, 2014 and March 31, 2015	—			—
Additional paid-in capital	522,919			~~525~~526,~~659~~292
Accumulated other comprehensive loss, net of tax	(11,871		)	(87,~~785~~547		)
Accumulated deficit	(370,400		)	(~~380~~383,~~601~~260		)
Total stockholder's equity	140,648			~~136~~135,~~273~~485
Total liabilities and stockholder's equity	$	1,576,056		$	1,~~539~~559,~~286~~178

The accompanying notes are an integral part of these condensed consolidated financial statements.

SRA INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(in thousands)

	Three months ended December 31,						Six months ended December 31,
	Three months ended March 31,						Nine months ended March 31,
	2013			2014			2013			2014
	2014			2015			2014			2015
Revenue	$	~~333~~355,~~713~~930		$	~~342~~349,~~018~~708		$	~~683~~1,~~536~~039,465		$	~~680~~1,~~633~~030,341
Operating costs and expenses:
Cost of services	~~260~~276,~~050~~319			~~264~~266,~~101~~861			~~524~~800,~~187~~506			~~519~~786,~~864~~725
Selling, general and administrative	4050,~~207~~004			4146,~~352~~364			85135,~~748~~751			86132,~~282~~646
Depreciation and amortization of property and equipment	2,~~323~~248			12,~~998~~096			47,~~908~~156			46,~~074~~170
Amortization of intangible assets	18,064			14,~~350~~351			3654,~~584~~647			2943,~~122~~473
Gain on the sale of a portion of the Health & Civil business	—			—			(1,564		)	—
Total operating costs and expenses	~~320~~346,~~644~~635			~~321~~329,~~801~~672			~~649~~996,~~863~~496			~~639~~969,~~342~~014
Operating income	139,~~069~~295			20,~~217~~036			3342,~~673~~969			4161,~~291~~327
Interest expense	(2625,~~356~~714		)	(26,~~566~~222		)	(5278,~~527~~241		)	(5380,~~840~~062		)
Interest income	249			911			3443			2334
Loss before income taxes	(1316,~~263~~410		)	(6,~~340~~175		)	(1835,~~820~~229		)	(1218,~~526~~701		)
Benefit from income taxes	(57,~~095~~122		)	(~~297~~3,516		)	(714,~~111~~233		)	(25,~~325~~841		)
Net loss	$	(89,~~168~~288	)	$	(62,~~043~~659	)	$	(1120,~~709~~996	)	$	(1012,~~201~~860	)

The accompanying notes are an integral part of these condensed consolidated financial statements.

SRA INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)

(in thousands)

	Three months ended December 31,						Six months ended December 31,
	Three months ended March 31,						Nine months ended March 31,
	2013			2014			2013			2014
	2014			2015			2014			2015
Net loss	$	(89,~~168~~288	)	$	(62,~~043~~659	)	$	(1120,~~709~~996	)	$	(1012,~~201~~860	)
Unrealized gain (loss) on interest rate swaps, net of tax	47			1,389			(48		)	3,086
Unrealized gain on interest rate swaps, net of tax	292			1,238			244			4,324
Comprehensive loss	$	(8,~~121~~996	)	$	(41,~~654~~421	)	$	(1120,~~757~~752	)	$	(78,~~115~~536	)

The accompanying notes are an integral part of these condensed consolidated financial statements.

SRA INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(in thousands)

	Six months ended December 31,
	Nine months ended March 31,
	2013			2014
	2014			2015
Cash flows from operating activities:
Net loss	$	(1120,~~709~~996	)	$	(1012,~~201~~860	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization of property and equipment	58,~~619~~279			46,~~739~~964
Amortization of intangible assets	3654,~~584~~647			2943,~~122~~473
Stock-based compensation	2,~~130~~565			23,~~786~~419
Deferred income taxes	(714,~~618~~819		)	(23,~~875~~604		)
Amortization of original issue discount and debt issuance costs	35,~~747~~563			35,~~640~~276
Gain on the sale of a portion of the Health & Civil business	(1,564		)	—
Changes in assets and liabilities, net of the effect of acquisitions and divestitures
Accounts receivable	117,~~399~~458			(93,~~341~~450		)
Prepaid expenses and other	3,~~697~~351			(24,~~054~~151		)
Accounts payable and accrued expenses	102,~~624~~046			~~(12~~15,~~093~~019		)
Accrued payroll and employee benefits	(75,~~899~~758		)	(~~746~~6,589		)
Billings in excess of revenue recognized	21,~~217~~712			(12,~~386~~448		)
Other	~~878~~7,790			~~685~~3,622
Net cash provided by operating activities	4850,~~105~~274			251,~~276~~571
Cash flows from investing activities:
Capital expenditures	(46,~~761~~968		)	(46,~~453~~126		)
Proceeds from the sale of a portion of the Health & Civil business	5,492			—
Net cash provided by (used in) investing activities	731			(4,453		)
Net cash used in investing activities	(1,476		)	(6,126		)
Cash flows from financing activities:
Borrowings under revolving credit facility	100,000			—
Repayments under revolving credit facility	(100,000		)	—
Repayments of Term Loan B Facility	—			(10,833		)
Net cash used in financing activities	—			(10,833		)
Net increase (decrease) in cash and cash equivalents	48,836			(13,010		)
Net increase in cash and cash equivalents	48,798			34,612
Cash and cash equivalents, beginning of period	5,050			108,840
Cash and cash equivalents, end of period	$	53,~~886~~848		$	95143,~~830~~452
Supplementary Cash Flow Information
Cash paid for interest	4983,~~114~~867			5662,~~189~~698
(Refunds received) cash paid for income taxes	(~~680~~1,304		)	1,~~485~~575

The accompanying notes are an integral part of these condensed consolidated financial statements.

SRA INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1. Basis of Presentation:

SRA International, Inc., a Virginia corporation, or SRA or the Company, was acquired on July 20, 2011 by private equity investment funds, or the PEP Funds, sponsored by Providence Equity Partners L.L.C., or Providence, collectively referred to as the Transaction. SRA is a wholly-owned subsidiary of Sterling Parent L.L.C., or Sterling Parent, which is wholly-owned by Sterling Holdco Inc., or Sterling Holdco, or collectively, the Parent. The Parent was formed by the PEP Funds for the purpose of the Transaction.

The accompanying unaudited condensed consolidated financial statements include the accounts of SRA and its wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP. Certain information and note disclosures normally included in the annual financial statements, which are also prepared in accordance with GAAP, have been omitted pursuant to those rules and regulations. The Company believes that the disclosures made are adequate to make the information presented not misleading.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments and reclassifications that are necessary for fair presentation of the periods presented. The results for the three and ~~six~~nine months ended ~~December~~March 31, ~~2014~~2015 are not necessarily indicative of the results to be expected for the full fiscal year. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the fiscal year ended June 30, 2014 included in the Company’s annual report on Form 10-K filed with the Securities and Exchange Commission on August 8, 2014.

Nature of Business

SRA provides technology and strategic consulting services and solutions primarily to U.S. federal government organizations. The Company provides services and solutions that enable mission performance, improve efficiency of operations, and/or reduce operating costs. The Company's portfolio of customers spans a broad variety of federal agencies and is organized around them into two business groups: National Security group and Health & Civil group.

Operating segments are components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker in allocating resources and in assessing performance. Due to the similarities in the types of customers, services and overall economic characteristics of the Company’s two business groups, the Company aggregates all of its operations into one reportable segment.

The Company derives a substantial portion of its revenue from services provided as a prime contractor or subcontractor on engagements with various agencies of the U.S. government. These contracts represented greater than 97% of the Company’s revenue for all periods presented. The Company considers individual agencies that may fall under a larger department as separate customers. No customer accounted for 10% or more of the Company’s revenue for any of the periods presented.

Fair Value Measurements

Fair value is the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between marketplace participants. Various valuation approaches can be used to determine fair value, each requiring different valuation inputs. The following hierarchy classifies the inputs used to determine fair value into three levels:


•	Level 1 – Quoted prices for identical instruments in active markets;


•	Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and


•	Level 3 – Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

The Company did not have any significant non-financial assets or liabilities measured at fair value on June 30, 2014 or ~~December~~March 31, ~~2014~~2015. However, the fair value measurement concepts are applied in determining the fair value of goodwill and intangible assets for the purposes of assessing impairment. The valuation models used in the impairment analysis are based in part on estimated future operating results and cash flows. Because these factors are derived from the Company's estimates and internal market assumptions, they are considered unobservable inputs and the resulting fair value measurements are included in Level 3 of the fair value hierarchy.

The Company’s financial instruments include cash, trade receivables, vendor payables, debt, and derivative financial instruments. As of June 30, 2014 and ~~December~~March 31, ~~2014~~2015, the carrying value of cash, trade receivables and vendor payables approximated their fair value. See Note 5 for a discussion of the fair value of the Company’s debt. See Note 6 for a discussion of the fair value of the Company’s derivative financial instruments.

Divestiture

On July 1, 2013, the Company sold a portion of its Health & Civil business, consisting of six contracts, for approximately $5.5 million. The Company recognized a gain of approximately $1.6 million during the ~~six~~nine months ended ~~December~~March 31, ~~2013~~2014 as a component of continuing operations. As a result of the divestiture, goodwill and intangible assets were reduced by approximately $4.2 million and $1.3 million, respectively.

Income Taxes

The Company's effective tax rate for the ~~six~~nine months ended ~~December~~March 31, ~~2013~~2014 and ~~2014~~2015 was a tax benefit of 3740.84% and 1831.62%, respectively. The Company's year to date fiscal 2014 effective tax rate was ~~lower~~higher than the statutory income tax rate primarily due to ~~non-deductible~~federal ~~permanent~~tax ~~items~~credits. The Company's year to date fiscal 2015 tax rate was lower than the statutory income tax rate as a result of adjusting tax benefits recognized previously in the financial statements and prior year tax returns.

Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board issued Accounting Standard Update, or ASU, 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. This ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. ~~The~~This ~~new~~ASU ~~standard~~ is effective for the Company's fiscal 2018. Early application is not permitted. ~~The~~This ~~standard~~ASU permits the use of either the retrospective or cumulative effect transition method. Management is ~~currently~~ evaluating the methods of adoption allowed by ~~the~~this ~~new~~ASU ~~standard~~ and the effect ~~the~~that ~~standard~~it is expected to have on the Company's consolidated financial statements.

In April 2015, the Financial Accounting Standards Board issued ASU 2015-03, Interest - Imputation of Interest, which requires the debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with the presentation of debt discounts. Adoption of this standard is not expected to have an impact on the Company's consolidated financial position, results of operations, or cash flows.

2. Stock-Based Compensation:

Stock Options

The Sterling Holdco Board of Directors adopted a stock incentive plan in February 2012, amended in December 2012, the 2012 Plan, that authorizes the issuance of up to 61,262 shares of common stock of Sterling Holdco in the form of options. Under the 2012 Plan, key employees, non-employee directors and consultants of the Company may be granted a combination of service and performance options. The performance options are considered market-based for accounting purposes. The Company utilizes the Black-Scholes-Merton model to value the service options and the Monte Carlo or binomial lattice model to value the performance options.

The service options generally vest in five equal installments subject to the option holder’s continued employment or service with the Company. The performance options vest at the time of a change in control based upon a specified level of cash return to the PEP Funds from its investment in the Company. The service and performance options expire 10 years from the date of grant.

The following table summarizes stock option activity for the ~~six~~nine months ended ~~December~~March 31, ~~2014~~2015:

Service Options:
Shares under option at June 30, 2014	26,071
Options granted	883
Options forfeited or cancelled	(1,316	)
Shares under option at December 31, 2014	25,638
Options exercisable at December 31, 2014	12,341
Performance Options:
Shares under option at June 30, 2014	25,957
Options granted	883
Options forfeited or cancelled	(617	)
Shares under option at December 31, 2014	26,223



Service Options:
Shares under option at June 30, 2014	26,071
Options granted	1,294
Options forfeited or cancelled	(1,331	)
Shares under option at March 31, 2015	26,034
Options exercisable at March 31, 2015	12,341

Performance Options:
Shares under option at June 30, 2014	25,957
Options granted	1,294
Options forfeited or cancelled	(617	)
Shares under option at March 31, 2015	26,634

Restricted Stock

In fiscal 2012, pursuant to the Chief Executive Officer’s, or CEO’s, employment agreement, the CEO was granted 1,000 shares of Sterling Holdco restricted stock at $1,000 per share. The restricted shares vest 20% per year on each of the first five anniversaries of the CEO’s date of employment with the Company.

In June 2013, the Sterling Holdco Board of Directors approved a restricted stock plan, the Restricted Stock Plan. The Board may award shares of restricted stock under the Restricted Stock Plan, at its discretion, to key employees. As of ~~December~~March 31, ~~2014~~2015, the number of authorized shares eligible for grant under the Restricted Stock Plan was 19,340 shares of Sterling Holdco’s common stock.

Vesting of restricted stock awarded under the Restricted Stock Plan is subject to the grantee’s continuous employment with the Company from the grant date to the vesting date. Awards vest over various time periods ranging from zero to 36 months. Vested restricted stock issued under the Restricted Stock Plan remains subject to certain sales and transfer restrictions.

The following table summarizes restricted stock activity for the ~~six~~nine months ended ~~December~~March 31, ~~2014~~2015:

Nonvested restricted shares of Sterling Holdco at June 30, 2014	12,076
Restricted shares granted	1,~~019~~300
Restricted shares vested	(2,~~236~~517	)
Restricted shares forfeited	(395	)
Nonvested restricted shares of Sterling Holdco at December 31, 2014	10,464
Nonvested restricted shares of Sterling Holdco at March 31, 2015	10,464

Stock Compensation Expense

The Company recognized stock-based compensation expense related to the stock options and restricted stock of $0.84 million and $0.6 million for the three months ended ~~December~~March 31, ~~2013~~2014 and ~~2014~~2015, respectively, and $2.16 million and $23.84 million for the ~~six~~nine months ended ~~December~~March 31, ~~2013~~2014 and ~~2014~~2015, respectively.

3. Accounts Receivable:

Accounts receivable, net as of June 30, 2014 and December 31, 2014 consisted of the following (in thousands):

	June 30, 2014			December 31, 2014
Billed and billable, net of allowance of $957 and $1,027 as of June 30, 2014 and December 31, 2014, respectively	$	201,427		$	208,020
Unbilled:
Retainages	4,031			4,514
Revenue recorded in excess of milestone billings on fixed-price contracts	12,595			14,775
Revenue recorded in excess of contractual authorization, billable upon receipt of contractual documents	5,184			4,723
Allowance for unbillable amounts	(5,560		)	(6,293		)
Total unbilled	16,250			17,719
Accounts receivable, net	$	217,677		$	225,739

The billable receivables included in the billed and billable line item above represent primarily revenue earned in the final month of the reporting period. Consistent with industry practice, certain receivables related to long-term contracts are classified as current, although $2.5 million of retainages are not expected to be billed and collected within one year. The Company’s accounts receivable are primarily from federal government agencies or customers engaged in work for the federal government. The Company believes there is no material credit risk associated with these receivables.

Billings in excess of revenue recognized totaled $10.8 million and $9.4 million at June 30, 2014 and December 31, 2014, respectively. Billings in excess of the revenue recognized are included in current liabilities in the condensed consolidated balance sheets.

During fiscal 2014, the Company entered into an accounts receivable purchase agreement under which the Company sells certain accounts receivable to a third party, or the Factor, without recourse to the Company. The Factor initially pays the Company 90% of the receivable and the remaining price is deferred and based on the amount the Factor receives from our customer. The structure of the transaction provides for a true sale, on a revolving basis, of the receivables transferred. Accordingly, upon transfer of the receivable to the Factor, the receivable is removed from the Company's condensed consolidated balance sheet, a loss on the sale is recorded and the deferred price is an account receivable until it is collected. The balance of the sold receivables may not exceed $50 million at any time. During the three and six months ended December 31, 2014, the Company sold approximately $102.6 million and $188.7 million of receivables, respectively, and recognized a related loss of approximately $0.2 million and $0.5 million in selling, general and administrative expenses for the same periods, respectively. As of December 31, 2014, the balance of the sold receivables was approximately $31.8 million, and the related deferred price was approximately $3.1 million.

3. Accounts Receivable:

Accounts receivable, net as of June 30, 2014 and March 31, 2015 consisted of the following (in thousands):



	June 30, 2014			March 31, 2015

Billed and billable, net of allowance of $957 and $969 as of June 30, 2014 and March 31, 2015, respectively	$	201,427		$	189,969
Unbilled:
Retainages	4,031			4,517
Revenue recorded in excess of milestone billings on fixed-price contracts	12,595			11,964
Revenue recorded in excess of contractual authorization, billable upon receipt of contractual documents	5,184			12,611
Allowance for unbillable amounts	(5,560		)	(6,402		)
Total unbilled	16,250			22,690
Accounts receivable, net	$	217,677		$	212,659

The billable receivables included in the billed and billable line item above represent primarily revenue earned in the final month of the reporting period. Consistent with industry practice, certain receivables related to long-term contracts are classified as current, although $2.6 million of retainages are not expected to be billed and collected within one year. The Company’s accounts receivable are primarily from federal government agencies or customers engaged in work for the federal government. The Company believes there is no material credit risk associated with these receivables.

Billings in excess of revenue recognized totaled $10.8 million and $8.4 million at June 30, 2014 and March 31, 2015, respectively. Billings in excess of the revenue recognized are included in current liabilities in the condensed consolidated balance sheets.

During fiscal 2014, the Company entered into an accounts receivable purchase agreement under which the Company sells certain accounts receivable to a third party, or the Factor, without recourse to the Company. The Factor initially pays the Company 90% of the receivable and the remaining price is deferred and based on the amount the Factor receives from the Company's customer. The structure of the transaction provides for a true sale, on a revolving basis, of the receivables transferred. Accordingly, upon transfer of the receivable to the Factor, the receivable is removed from the Company's condensed consolidated balance sheet, a loss on the sale is recorded and the deferred price is an account receivable until it is collected. The balance of the sold receivables may not exceed $50 million at any time. During the three and nine months ended March 31, 2014, the Company sold $50.0 million of receivables and recognized a related loss of $0.2 million in selling, general and administrative expenses. During the three and nine months ended March 31, 2015, the Company sold $103.4 million and $292.1 million of receivables, respectively, and recognized a related loss of $0.2 million and $0.7 million in selling, general and administrative expenses for the same periods, respectively. As of March 31, 2015, the balance of the sold receivables was $29.5 million, and the related deferred price was $3.2 million.

4. Composition of Certain Financial Statement Captions:

Details of the composition of certain financial statement captions for the periods presented were as follows (in thousands):

	June 30, 2014			~~December~~March 31, ~~2014~~2015
Prepaid expenses and other
Taxes and taxes receivable	$	—		$	122,393
Maintenance and software	1,575			21,~~251~~884
Rent	237			~~318~~269
Other	3,831			5,~~116~~248
Total prepaid expenses and other	$	5,643		$	79,~~697~~794
Property and equipment
Leasehold improvements	$	22,482		$	23,~~039~~315
Furniture, equipment and software	32,185			34,~~402~~657
Total property and equipment	54,667			57,~~441~~972
Less: Accumulated depreciation and amortization	(35,742		)	(3840,~~957~~573		)
Total property and equipment, net	$	18,925		$	1817,~~484~~399
Identified intangibles
Acquired intangible assets	$	501,699		$	501,699
Software development costs	2,930			3,~~036~~167
Total identified intangibles	504,629			504,~~735~~866
Less: Accumulated amortization	(250,713		)	(~~279~~294,~~835~~186		)
Total identified intangibles, net	$	253,916		$	~~224~~210,~~900~~680
Other long-term assets
Debt issuance costs, net	$	31,566		$	2827,~~471~~059
Other	4,066			3,~~680~~650
Total other long-term assets	$	35,632		$	3230,~~151~~709
Accounts payable and accrued expenses
Vendor obligations	$	86,658		$	7888,~~722~~465
Accrued interest	23,215			1735,~~196~~273
Interest rate derivative liability	10,729			107,~~416~~848
Facility exit charge	8,173			5,~~868~~405
Other	7,851			1211,~~384~~854
Total accounts payable and accrued expenses	$	136,626		$	~~124~~148,~~586~~845
Accrued payroll and employee benefits
Accrued salaries and incentive compensation	$	35,195		$	3437,~~955~~979
Accrued leave	33,694			2930,~~260~~399
Other	14,128			188,~~056~~050
Total accrued payroll and employee benefits	$	83,017		$	8276,~~271~~428
Other long-term liabilities
Interest rate derivative liability	$	8,803		$	4,~~039~~571
Deferred rent	9,433			911,~~937~~233
Facility exit charge	5,193			34,~~227~~917
Other	1,312			~~486~~—
Total other long-term liabilities	$	24,741		$	1720,~~689~~721

1011

5. Debt:

On July 20, 2011, in connection with the Transaction, the Company (i) entered into senior secured credit facilities, consisting of an $875.0 million Term Loan B Facility and a $100.0 million Revolver, or the Credit Agreement, and (ii) issued $400.0 million aggregate principal amount of 11% Senior Notes. The Term Loan B Facility was issued at a discount of $8.75 million.

At June 30, 2014 and ~~December~~March 31, ~~2014~~2015, debt consisted of the following (in thousands):

	June 30, 2014			~~December~~March 31, ~~2014~~2015
Secured Term Loan B Facility	$	675,000		$	664,167
Less: Unamortized discount	(5,073		)	(4,~~528~~304		)
Secured Term Loan B Facility, net	669,927			659,~~639~~863
Senior Notes due 2019 at 11%	400,000			400,000
Total debt	1,069,927			1,059,~~639~~863
Current portion of long-term debt	(22,000		)	~~(30,000~~—		)
Long-term debt	$	1,047,927		$	1,~~029~~059,~~639~~863

As of ~~December~~March 31, ~~2014~~2015, the estimated fair value of the Company’s outstanding debt was approximately $1,~~087~~092.73 million. The estimated fair value of ~~our~~this outstanding debt was determined based on quoted prices for similar instruments in active markets (Level 2 inputs).

The senior secured credit facilities and the indenture governing the Senior Notes issued in connection with the Transaction limit the Company’s ability to incur certain additional indebtedness, pay dividends or make other distributions or repurchase capital stock, make certain investments, enter into certain types of transactions with affiliates, use assets as security in other transactions, and sell certain assets.

The Company is required to meet a net senior secured leverage ratio, or NSSLR, covenant quarterly if any revolving loan, swing-line loan or letter of credit is outstanding on the last day of the quarter. The Company had no outstanding debt, letters of credit or borrowings on its Revolver as of June 30, 2014 and ~~December~~ March 31, ~~2014~~2015. If the Company had any borrowings on its Revolver, it would have been required to maintain a NSSLR of less than or equal to 4.~~75x~~5x as of ~~December~~March 31, ~~2014~~2015. The ~~NSSLR requirement decreases over time to 4.5x as of June 30, 2016. The~~ ratio is calculated as the consolidated net secured indebtedness as of the last day of the quarter (defined as the consolidated net debt secured by any lien minus any cash and permitted investments) to the preceding four quarters’ consolidated EBITDA, excluding the impact of acquisition made subsequent to the reporting period (as defined in the Credit Agreement). See Note 10 for the discussion of the acquisition. The Company’s NSSLR was 3.2x as of June 30, 2014 and 32.2x9x as of ~~December~~March 31, ~~2014~~2015. As of ~~December~~March 31, ~~2014~~2015, the Company was in compliance with all of its covenants.

Senior Secured Credit Facilities

Borrowings under the senior secured credit facilities bear interest at a rate equal to an applicable margin plus London Interbank Offered Rate, or LIBOR, with a 1.25% floor, or, at the Company’s option, an applicable margin plus an alternative base rate determined by reference to the higher of the prime rate or the federal funds rate plus 0.5%, with a 2.25% floor. In addition to paying interest on outstanding principal under the senior secured credit facilities, the Company pays a per annum commitment fee on undrawn amounts under the revolving credit facility and customary administrative fees. The senior secured credit facilities are guaranteed by the Company’s wholly-owned subsidiaries and by Sterling Parent. The Term Loan B Facility matures in July 2018 and the Revolver matures in July 2016.

In addition, the senior secured credit facilities require the Company to prepay outstanding term loans, subject to certain exceptions, in the case of excess cash flow, or ECF, and in the event of certain asset sales, condemnation events and issuances of debt. The Company is required to make annual payments equal to 50% of ECF based upon achievement of a net senior secured leverage ratio, or NSSLR, between 2.75x and 3.5x. The required annual payments adjust to 75% of ECF when NSSLR is greater than 3.5x, 25% of ECF when NSSLR is between 2x and 2.75x, and zero if ~~NSSRL~~NSSLR is less than 2x. Any required ECF payments are due in October each year, subject to acceptance by the lenders. The Company repaid $140.0 million of its Term Loan B Facility in fiscal 2012, which satisfied all of the Company’s required quarterly principal payments and required ECF principal payments for fiscal 2012. The Company repaid $20.0 million of its Term Loan B Facility in fiscal 2013, which satisfied the Company’s required ECF principal payments for fiscal 2013. The Company's fiscal 2014 ECF requirement was $61.5 million, of which the Company repaid $40.0 million during fiscal 2014. The remainder was tendered as payment in October 2014, of which $10.6 million was declined by the lenders and returned to the Company, as permitted by the facility.

1112

~~Company~~The ~~repaid~~ $408.075 million ~~during~~Term ~~fiscal~~Loan ~~2014~~B Facility original issue discount is being amortized to interest expense using the effective interest method and added to the recorded debt amount over the seven-year term of the loan. ~~The~~During ~~remainder~~the ~~was~~three ~~tendered~~months asended ~~payment~~March 31, in2014 ~~October~~and 2015 and the nine months ended March 31, 2014 and 2015, of$0.3 ~~which~~million, $100.62 million, ~~was~~$0.9 ~~declined~~million byand $0.8 million of the ~~lenders~~original issue discount were amortized and ~~returned~~reflected toin interest expense in the ~~Company,~~condensed asconsolidated ~~permitted~~statements byof ~~the~~operations, ~~facility~~respectively.

~~The~~Costs ~~$8.75~~incurred ~~million~~in ~~Term~~connection ~~Loan~~with Bthe ~~Facility~~issuance ~~original~~of ~~issue~~the ~~discount~~debt isare ~~being~~ amortized ~~to interest expense~~ using the effective interest method ~~and~~over ~~added~~the tolife of the ~~recorded~~related debt ~~amount~~and ~~over~~accelerated to the ~~seven-year~~extent ~~term~~that ofany ~~the~~repayment ~~loan~~is made. During the three months ended ~~December~~March 31, ~~2013~~2014 and ~~2014~~2015 and the ~~six~~nine months ended ~~December~~March 31, ~~2013~~2014 and ~~2014~~2015, $01.35 million, $01.24 million, $04.67 million and $04.5 million of ~~the~~costs ~~original issue discount~~ were amortized and reflected in interest expense in the condensed consolidated statements of operations, respectively.

~~Costs~~As ~~incurred~~of inMarch 31, ~~connection~~2015, ~~with~~interest ~~the~~accrued ~~issuance~~at ofa ~~the~~rate ~~debt~~of ~~are~~6.5% ~~amortized~~for ~~using~~ the ~~effective~~senior ~~interest~~secured ~~method~~credit ~~over~~facilities. ~~the~~Interest ~~life~~payments of ~~the~~$11.6 ~~related~~million ~~debt~~ and ~~accelerated~~$3.8 tomillion ~~the~~were ~~extent that any repayment is~~ made. ~~During~~in the three months ended ~~December~~March 31, ~~2013 and~~ 2014 and ~~the~~2015, ~~six~~respectively, ~~months~~including ~~ended~~$0.2 ~~December 31,~~million ~~2013~~ and ~~2014,~~ $10.52 million, $1of commitment fees for the same periods.4 ~~million,~~Interest payments of $336.24 million and $334.10 million ofwere ~~costs~~made ~~were~~in ~~amortized~~the ~~and~~nine ~~reflected~~months inended ~~interest~~March 31, ~~expense~~2014 inand ~~the~~2015, ~~condensed~~respectively, ~~consolidated~~including ~~statements~~$0.6 million and $0.5 million of ~~operations,~~commitment ~~respectively~~fees for the same periods.

As of December 31, 2014, interest accrued at a rate of 6.5% for the senior secured credit facilities. Interest payments of $12.5 million and $11.3 million were made in the three months ended December 31, 2013 and 2014, respectively, including $0.1 million and $0.2 million of commitment fees for the same periods. Interest payments of $24.7 million and $30.2 million were made in the six months ended December 31, 2013 and 2014, respectively, including $0.4 million and $0.3 million of commitment fees for the same periods.

Senior Notes due 2019

The Senior Notes due 2019 are guaranteed by all of the Company’s wholly-owned subsidiaries. The guarantees are full and unconditional and joint and several. Each of the subsidiary guarantors are 100% owned by the Company and have no independent assets or operations.

Interest on the Senior Notes is payable semi-annually. The Senior Notes are redeemable in whole or in part, at the option of the Company, at varying redemption prices that generally include premiums. As of ~~December~~March 31, ~~2014~~2015, interest accrued at 11.0% for the Senior Notes. The Company paid $22.0 million and $44.0 million of interest related to the Senior Notes in the three and nine months ended ~~December~~ March 31, 2014. The Company paid zero and $22.0 million of interest related to the ~~six~~Senior Notes in the three and nine months ended ~~December~~ March 31, ~~2013 and 2014~~2015.

6. Derivative Instruments and Hedging Activities:

Hedge of Interest Rate Risk

Risk Management Objective of Using Derivatives

The Company utilizes derivative financial instruments to manage interest rate risk related to its Term Loan B Facility.

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company uses interest rate swaps as part of its interest rate risk management strategy. Such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. As of June 30, 2014 and ~~December~~March 31, ~~2014~~2015, the Company had outstanding interest rate derivatives with a combined notional value of $565.0 million and $500.0 million, respectively, which were designated as cash flow hedges of interest rate risk. The interest rate swap derivatives decrease over time to a notional value of $475.0 million upon maturity in July 2016.

The effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in Accumulated Other Comprehensive Income, or AOCI, net of taxes, and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings. Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. During the next twelve months, the Company estimates that approximately $6.3 million will be reclassified from AOCI into earnings.

Fair Values of Derivative Instruments on the Condensed Consolidated Balance Sheets

The fair value of the Company’s derivative financial instruments, determined using Level 2 inputs (see Note 1), was $19.5 million and $1412.54 million as of June 30, 2014 and ~~December~~March 31, ~~2014~~2015, respectively. The current portion is included in the accounts payable and accrued expenses and the long-term portion is included in other long-term liabilities in the condensed consolidated balance sheets.

12The Company utilizes a third-party pricing service to assist with determining the fair values for its interest rate swaps. The Company performs procedures to corroborate the values provided by the pricing service including regular discussions to understand

The Company utilizes a third-party pricing service to assist with determining the fair values for its interest rate swaps. The Company performs procedures to corroborate the values provided by the pricing service including regular discussions to understand the pricing service’s methodology and a review of the service provider’s Statement on Standards for Attestation Engagements No. 16, or SSAE 16, report.13

the pricing service’s methodology and a review of the service provider’s Statement on Standards for Attestation Engagements No. 16, or SSAE 16, report.

The Effect of Derivative Instruments on the Condensed Consolidated Statements of Operations & Condensed Consolidated Statements of Comprehensive Loss

All amounts recorded in other comprehensive loss are related to the Company’s derivatives. The following table represents a rollforward of amounts recognized in accumulated other comprehensive loss, including the reclassifications out of the accumulated other comprehensive loss to the condensed consolidated statements of operations (in thousands):

	Three months ended December 31,						Six months ended December 31,
	Three months ended March 31,						Nine months ended March 31,
	2013			2014			2013			2014
	2014			2015			2014			2015
Beginning of period	$	(12,~~278~~231	)	$	(108,~~174~~785	)	$	(12,183	)	$	(11,871	)
Other comprehensive loss before reclassifications
Total before tax	(~~1,064~~635		)	(~~430~~619		)	(23,~~413~~047		)	(~~489~~1,108		)
Tax effect	~~417~~249			~~169~~243			~~946~~1,195			~~192~~435
Net of tax	(~~647~~386		)	(~~261~~376		)	(1,~~467~~852		)	(~~297~~673		)
Amounts reclassified from accumulated other comprehensive income (loss)
Amounts reclassified from accumulated other comprehensive loss
Total before tax	1,~~141~~116			2,~~715~~656			23,~~334~~449			58,~~566~~222
Tax effect	(~~447~~438		)	(1,~~065~~042		)	(~~915~~1,353		)	(23,~~183~~225		)
Net of tax	~~694~~678			1,~~650~~614			12,~~419~~096			34,~~383~~997
Net other comprehensive income (loss)	47			1,389			(48		)	3,086
Net other comprehensive income	292			1,238			244			4,324
End of period	$	(1211,~~231~~939	)	$	(87,~~785~~547	)	$	(1211,~~231~~939	)	$	(87,~~785~~547	)

Credit Risk-Related Contingent Features

The Company has agreements with each of its interest rate swap counterparties that contain a provision providing that the Company could be declared in default on its derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to the Company's default on the indebtedness.

If the Company had breached any of the provisions of the agreements at ~~December~~March 31, ~~2014~~2015, it could have been required to settle its obligations under the agreements at an estimated termination value. As of ~~December~~March 31, ~~2014~~2015, the termination value of the interest rate swaps in a net liability position, which includes accrued interest but excludes any adjustment for nonperformance risk related to these agreements, was $1715.85 million. As of ~~December~~March 31, ~~2014~~2015, the Company was not in breach of any of the provisions nor posted any collateral related to these agreements.

7. Commitments and Contingencies:

Government Contracting

The Company is subject to investigations and reviews relating to compliance with various laws and regulations. U.S. Government agencies, including the Defense Contract Audit Agency, or DCAA, and the Defense Contract Management Agency, or DCMA, routinely audit and review a contractor’s performance on government contracts; accounting, estimating, and other management internal control systems; indirect rates and pricing practices; and compliance with applicable contracting and procurement laws, regulations and standards, including U.S. Government Cost Accounting Standards.

In November 2013, DCMA issued a report that deemed the Company’s accounting system acceptable. Any future adverse audit findings or failure to obtain an “adequate” determination of the Company’s various accounting, estimating, and other management internal control systems from the responsible U.S. government agency could significantly and adversely affect its business, including its ability to bid on new contracts and its competitive position in the bidding process. The government may also decrement billings until cited deficiencies are corrected and a follow-up review has been performed by DCAA confirming corrective actions are adequate.

1314

~~also~~The ~~decrement~~DCAA ~~billings~~has ~~until~~not ~~cited~~completed ~~deficiencies~~audits ~~are~~of ~~corrected~~the Company’s incurred cost submissions for fiscal 2009 and asubsequent ~~follow-up~~fiscal ~~review~~years. The Company has ~~been~~recorded ~~performed~~financial byresults ~~DCAA~~subsequent ~~confirming~~to ~~corrective~~fiscal ~~actions~~2008 ~~are~~based ~~adequate~~upon costs that the Company believes will be approved upon final audit or review. If incurred cost audits result in adverse findings that exceed the Company’s estimates, it may have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.

The DCAA has not completed audits of the Company’s incurred cost submissions for fiscal 2008 and subsequent fiscal years. The Company has recorded financial results subsequent to fiscal 2007 based upon costs that the Company believes will be approved upon final audit or review. If incurred cost audits result in adverse findings that exceed the Company’s estimates, it may have a material adverse effect on the Company’s financial position, results of operations or cash flows.

Litigation

The Company is subject to investigations, audits and reviews relating to compliance with various laws and regulations with respect to its role as a contractor to agencies and departments of the U.S. Government, state, local, and foreign governments, and otherwise in connection with performing services in countries outside of the United States. Such matters can lead to criminal, civil or administrative proceedings and the Company could be faced with penalties, fines, payments or compensatory damages. Adverse findings could also have a material adverse effect on the Company because of its reliance on government contracts. The Company is subject to periodic audits by state, local, and foreign governments for taxes. The Company is also involved in various claims, arbitrations and lawsuits arising in the normal conduct of its business, including but not limited to bid protests, various employment litigation matters, contractual disputes and charges before administrative agencies. Although the Company can give no assurance, based upon its evaluation and taking into account the advice of legal counsel, the Company does not believe that the outcome of any such matter would likely have a material adverse effect on the Company’s consolidated financial position, results of operations, or cash flows.

8. Facility Exit Costs:

Periodically the Company initiates activities to consolidate and exit certain underutilized leased facilities as well as sublease excess space. The Company exited underutilized office space in several of its leased facilities and recognized total facility exit charges of $08.41 million and $08.56 million during the three and ~~six~~nine months ended ~~December~~March 31, ~~2013~~2014, respectively. During the three ~~and six~~ months ended ~~December~~ March 31, ~~2014~~2015, the Company recognized facility exit charges of $03.59 million ~~and~~including $10.89 million related to less favorable sublease assumptions. During the nine months ended March 31, ~~respectively~~2015, the Company recognized facility exit charges of $4.8 million, offset by a reduction in the facility exit charge of $21.45 million due to negotiating more favorable sublease terms than were previously estimated. Future lease payments will continue to be made through the end of the lease terms, with the latest expiring in fiscal 2026.

In determining the fair value of the facility exit charges, the Company made estimates related to potential sublease income and future exit costs. If the actual amounts differ from the Company’s estimates, the amount of the facility exit charges could be impacted.

The following is a summary of the accrued facility exit charge (in thousands). The current portion is included in accounts payable and accrued expenses and the long-term portion is included in other long-term liabilities in the condensed consolidated balance sheets.

Balance as of June 30, 2014	$	13,366
Facility exit costs accrued, net	~~(551~~3,304		)
Cash payments	(35,~~556~~931		)
Other	(~~164~~417		)
Balance as of December 31, 2014	9,095
Balance as of March 31, 2015	10,322
Current portion of facility exit charge liability	(5,~~868~~405		)
Long-term facility exit charge liability	$	34,~~227~~917

9. Related Party Transactions:

In accordance with the Transaction, Providence provides the Company with advisory, consulting, and other services for which the Company pays Providence an annual management fee. In addition to the management fee, the Company is responsible for expenses incurred by Providence in connection with its performance of oversight services. The Company incurred $0.4 million and $0.45 million in management fees and expenses for the three months ended ~~December~~March 31, ~~2013~~2014 and ~~2014~~2015, respectively, and $01.93 million and $01.94 million for the ~~six~~nine months ended ~~December~~ March 31, ~~2013~~2014 and ~~2014~~2015, respectively.

From time to time, and in the ordinary course of business, the Company purchases goods and services from other Providence portfolio companies. Costs associated with these related party transactions for the three months ended ~~December~~March 31, ~~2013~~2014 and 2015 were $2.4 million and $4.0 million, respectively, and $4.7 million and $7.6 million for the nine months ended March 31, 2014 and 2015, respectively.

1415

As of June 30, 2014, there were ~~$1.2~~no ~~million~~amounts due from related parties and $20.26 million, ~~respectively~~due to related parties, which was included in accounts payable and $2accrued expenses in the accompanying condensed consolidated balance sheet.3 ~~million~~As of March 31, 2015, there were no amounts due from related parties and $30.62 million ~~for~~due ~~the~~to ~~six~~related ~~months~~parties, ~~ended~~which ~~December~~was ~~31,~~included ~~2013~~in accounts payable and ~~2014,~~accrued ~~respectively~~expenses in the accompanying condensed consolidated balance sheet.

~~As of June 30, 2014, there were no amounts due from related parties and $0~~10.6 ~~million~~Subsequent due to related parties, which was included in accounts payable and accrued expenses in the accompanying condensed consolidated balance sheet. As of December 31, 2014, there were no amounts due from related parties and $0.3 million due to related parties, which was included in accounts payable and accrued expenses in the accompanying condensed consolidated balance sheet. Events:

On April 15, 2015, the Company completed an asset purchase of substantially all of the Government Services business from Qbase LLC for $72.0 million. The acquired Qbase Government Services business delivers IT support solutions and professional services to help enable the U.S. government's missions focused on health, IT, homeland security and law enforcement. The acquisition was financed with cash on hand. The asset purchase agreement contains customary representations and warranties and requires Qbase and certain controlling stockholders to indemnify the Company for certain contingent liabilities for which an escrow fund of $5.4 million was established. The Company expects to complete the purchase price allocation in the fourth quarter.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The discussion and analysis that follows is organized to:

•provide an overview of our business;

•describe selected key metrics evaluated by management;

•explain the year-over-year trends in our results of operations;

•describe our liquidity and capital resources; and

•explain our critical accounting policies and estimates.

Readers who are not familiar with our company or the financial statements of federal government information technology, or IT, service providers should closely review the "Description of Critical Accounting Policies and Estimates," and the "Description of Statement of Operations Items," sections included in our annual report on Form 10-K filed with the Securities and Exchange Commission on August 8, 2014. These sections provide background information that can help readers understand and analyze our financial information.

Overview

We are a leading provider of technology and strategic consulting services and solutions primarily to U.S. federal government organizations. Founded in 1978, we are dedicated to solving complex mission and efficiency challenges for our customers by providing ~~information technology, or~~ IT, solutions and professional services that enable mission performance, improve efficiency of operations or reduce operating costs. Our IT service offerings include infrastructure services, software development, systems integration, cybersecurity, cloud computing, business intelligence, data analytics and mobile solutions. We also provide mission-specific domain expertise in areas such as intelligence analysis;, energy and environmental consulting;, enterprise logistics; and bioinformatics. We currently serve more than 200 federal government organizations, across National Security and Health & Civil markets, many of which we have served for over 20 years. Revenue from the federal government ~~market~~ represented greater than 97% for all periods presented. Our revenue and Adjusted EBITDA (as calculated in accordance with our credit agreement) were $~~342~~349.07 million and $3847.42 million for the three months ended ~~December~~March 31, ~~2014~~2015, respectively, and $~~680~~1,030.63 million and $83140.67 million for the ~~six~~nine months ended ~~December~~March 31, ~~2014~~2015, respectively. For a reconciliation of Adjusted EBITDA to net loss, see the section entitled “Items Affecting the Comparability of our Operating Results.”

Forward-Looking Statements

Some of the statements under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this quarterly report on Form 10-Q constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify these statements by forward-looking words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “should,” “will,” and “would” or similar words. You should read statements that contain these words carefully because they discuss our future expectations, contain projections of our future results of operations or of our financial position, or state other forward-looking information. We believe that it is important to communicate our future expectations to our investors. However, there may be events in the future that we are not able to predict accurately or control. The factors listed in the “Risk Factors” section of our annual report on Form 10-K filed with the Securities and Exchange Commission, or SEC, on August 8, 2014 and this quarterly report on Form 10-Q, provide some, but not all possible examples of risks, uncertainties and events that may cause our actual results to differ materially from the expectations we describe in our forward-looking statements.

1516

2014 and this quarterly report on Form 10-Q, provide some, but not all, possible examples of risks, uncertainties and events that may cause our actual results to differ materially from the expectations we describe in our forward-looking statements.

Factors or risks that could cause our actual results to differ materially from the results we anticipate include, but are not limited to:


•	reduced spending levels and changing budget priorities of our largest customer, the United States federal government, which accounts for greater than 97% of our revenue;

• failure of our customer to fund a contract or exercise options to extend contracts, or our inability to successfully execute awarded contracts or otherwise convert our backlog into revenue;

• automatic across-the-board spending cuts to civil and defense programs as a result of the 2011 sequester, the 2013 government shutdowns or other budget constraints;


•	limitations as a result of our substantial indebtedness which could adversely affect our financial health, operational flexibility and strategic plans;


•	failure to generate cash sufficient to pay the principal of, interest on, or other amounts due on our debt;


•	failure to comply with complex laws and regulations, including but not limited to, the False Claims Act, the Federal Acquisition Regulation, the Defense Federal Acquisition Regulation Supplement and the U.S. Government Cost Accounting Standards;


•	possible delays or overturning of our government contract awards due to bid protests, loss of contract revenue or diminished opportunities based on the existence of organizational conflicts of interest or failure to perform by other companies on which we depend to deliver products and services;


•	security threats, attacks or other disruptions on our information infrastructure, and failure to comply with complex network security and data privacy legal and contractual obligations or to protect sensitive information;


•	inability or failure to adequately protect our proprietary information or intellectual property rights or violation of third party intellectual rights;


•	potential for significant economic or personal liabilities resulting from failures, errors, delays or defects associated with products, services and systems we supply including risks associated with work performed through joint venture arrangements;


•	adverse changes in federal government practices;


•	pricing pressure on new work, reduced profitability or loss of market share due to intense competition and commoditization of services we offer;

•

adverse results of audits and investigations conducted by the Defense Contract Audit Agency, Internal Revenue Service or any of the Inspectors General for various agencies with which we contract, including, without limitation, any determination that our purchasing, property, estimating, cost accounting, labor, billing, compensation, management information systems or contractor internal control systems are deficient;

• adverse determinations of any tax authority successfully challenging ~~the~~our ~~Company’s~~ operational structure, transfer pricing policies, or the taxable presence of ~~its~~our remaining subsidiaries in certain countries, or a finding against ~~the~~us ~~Company~~ in a material tax dispute could increase ~~its~~our effective tax rate on ~~its~~our earnings and materially decrease earnings and negatively affect cash flows from operations;


•	difficulties accurately estimating contract costs and contract performance requirements;


•	possible further impairment of goodwill, trade names and other assets as a result of customer budget pressures and reduced U.S. federal government spending;


•	challenges attracting and retaining key personnel or high-quality employees, particularly those with security clearances;

1617

• failure to manage acquisitions or divestitures successfully, including identifying, evaluating, and valuing acquisition targets, integrating acquired companies, businesses or assets, losses associated with divestitures, and the inability to effect divestitures at attractive prices and on a desired timeline;


•	possible future losses that exceed our insurance coverage;


•	pending litigation and any resulting expenses, payments or sanctions, including but not limited to penalties, compensatory damages or suspension or debarment from future government contracting; and


•	the effect of our acquisition by entities affiliated with Providence on our business relationships, operating results and business generally.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this quarterly report on Form 10-Q. Subsequent events and developments may cause our views to change. While we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, except as required by law.

Non-GAAP Financial Measures

Adjusted EBITDA presented in this section is a supplemental measure that is not required by, or presented in accordance with generally accepted accounting principles, or GAAP. This non-GAAP measure is not a measurement of our financial performance under GAAP and should not be considered as an alternative to net income, operating income, or any other performance measure derived in accordance with GAAP. In addition, our calculations of this non-GAAP measure may not be comparable to that of other companies. We believe this measure is frequently used by securities analysts, investors, and other interested parties in the evaluation of high-yield issuers, as well as management to assess operating performance.

Business Environment and Outlook

We generate greater than 97% of our revenue from services provided as a prime contractor or subcontractor on engagements with various agencies of the U.S. federal government. Accordingly, our business performance is affected by the overall level of federal spending.

In recent years, the government has faced fiscal and economic challenges that have created pressure to identify efficiencies in discretionary spending. Those challenges adversely affected our industry’s financial performance from 2011 to 2013 but have eased somewhat since early 2014. In certain market segments, contract awards continue to face delays, pricing pressure and greater numbers of competitors, but we have observed fewer instances of contract scope reductions, and funding pressure has lessened over the past year.

The sequester cuts enacted by the Budget Control Act of 2011 reduced spending levels in most federal agencies, and the government shutdown in October 2013 discontinued many federal functions and associated contractor support for approximately two weeks. In December 2013, the President signed the Bipartisan Budget Act of 2013, which revised the limits on discretionary appropriations for government fiscal years 2014 and 2015, providing for higher levels of funding in those years than were allowed under the prior caps and budget enforcement procedures. On October 1, 2014, the government’s fiscal year 2015 began under a Continuing Resolution. In ~~December~~The ~~2014,~~government ~~the~~has ~~President~~since ~~signed~~been ~~an omnibus spending bill that~~ funded ~~most~~by ofa ~~the~~December ~~government~~2014 ~~for~~omnibus ~~the~~spending ~~remainder~~bill ofand ~~its~~subsequent ~~fiscal year~~bills.

Given that our business is broadly distributed across the federal government, we are well positioned to invest and grow in the most attractive market segments. Years of budget pressure have led to a growing backlog of IT needs that have not been fully addressed. We expect our customers to make critical investments in areas such as cybersecurity, operating efficiency, Command, Control, Communications, Computers, Intelligence, Surveillance and Reconnaissance, or C4ISR, and health care system modernization, and to continue supporting homeland security and special forces capabilities. We have ~~very~~ limited exposure to areas of the budget that face the most significant ongoing pressure, such as Overseas Contingency Operations spending in the Defense Department, which relates to less than 1% of our business portfolio.

Since fiscal 2011, we have streamlined our cost structure and focused our investments in high-priority markets and technologies. We have increased our annual investments in business development, capture and proposal activities, while significantly reducing our overall selling, general and administrative expenses, or SG&A, through reductions in our indirect labor force, consolidation and reconfiguration of underutilized office space, and reduction of fringe benefits. In fiscal 2014, we created additional efficiencies by realigning our business into two groups and exiting several underutilized facilities. We have also undertaken initiatives to improve the profitability of our contract base, invest in our workforce, provide career mobility, and further collaborate internally in order to optimize business performance.

1718

We continue to believe we are well positioned to gain market share and achieve long-term growth, and this belief has been validated by our improved win rates, the quality of our bids, and contract award volume since the beginning of fiscal 2014. With less than two percent market share in federal IT and professional services, we ~~feel~~believe ~~that~~ there are sufficient new business opportunities in our market to drive revenue growth and we continue to invest in our capacity to address them.

Key Metrics

We manage and assess the performance of our business by evaluating a variety of metrics. Selected key metrics are discussed below.

Contract Backlog

We define backlog as our estimate of the remaining future revenues from existing signed contracts. Our backlog includes funded and unfunded orders for services under existing signed contracts, assuming the exercise of all option years relating to those contracts, less the amount of revenue we have previously recognized under those contracts and de-obligations. Backlog includes all contract options that have been priced but not yet funded. Backlog also includes an estimate of the contract value under single award indefinite delivery/indefinite quantity, or ID/IQ, contracts against which we expect future task orders to be issued without competition. Backlog does not take contract ceiling value into consideration under multiple award contracts, nor does it include any estimate of future potential delivery orders that might be awarded under multiple award ID/IQ vehicles, government-wide acquisition contracts, or GWACs, or General Services Administration, or GSA, schedule contracts. We define funded backlog to be the portion of backlog for which funding currently is appropriated and obligated to us under a contract or other authorization for payment signed by an authorized purchasing authority.

Our future growth is dependent upon the strength of our target markets, our ability to identify opportunities, and our ability to successfully bid and win new contracts. New contract awards or orders generally represent the amount of revenue expected to be earned in the future from funded and unfunded contract awards received during the period. Ceiling increases result from upward contract adjustments under existing contracts and increases in scope. “De-obligations and removals” refers to the removal from backlog of amounts previously awarded by a customer resulting from either (i) a formal contract modification issued by the customer reducing, or de-obligating, the remaining contract value, or (ii) the expiration of the period of performance without an extension issued by the customer which would be necessary for us to continue working under the contract. In the latter case we remove the remaining contract value from backlog even though the contract value is not formally de-obligated by the customer.

(in millions)	Three Months Ended ~~December~~March 31, ~~2014~~2015			~~Six~~Nine Months Ended ~~December~~March 31, ~~2014~~2015
Beginning backlog	$	3,~~552~~375.34		$	3,478.4
New contact awards	93.6			383.9
New contract awards	228.9			612.8
Ceiling increases	~~107~~81.62			~~270~~351.35
Total contract awards	~~201~~310.21			~~654~~964.23
De-obligations and removals	(3695.18		)	(76172.64		)
Net orders	~~165~~214.13			~~577~~791.69
Revenue recognized	(~~342~~349.07		)	(~~680~~1,030.63		)
Ending backlog	3,~~375~~240.40			3,~~375~~240.40
Funded	$	~~739~~604.0		$	~~739~~604.0
Unfunded	2,636.40			2,636.40
Total backlog	$	3,~~375~~240.40		$	3,~~375~~240.40

A key measure of our business growth is the ratio of total contracts awarded compared to the revenue recorded in the same period, or book-to-bill ratio. Our goal is for the level of business awards to exceed the revenue booked in order to drive future revenue growth. Our book-to-bill ratio, calculated using total contract orders, was 0.69:1, 1.0.9:1 and 1.1:1 for the three, ~~six~~nine and twelve months ended ~~December~~March 31, ~~2014~~2015, respectively.

With over $100 billion of annual spending on federal ~~information~~IT ~~technology~~ and professional services, our addressable market continues to support a large pipeline of new business opportunities. The total value of proposals we submitted in the ~~six~~nine months ended ~~December~~March 31, ~~2014~~2015 was $25.40 billion. Submittals include the total value of bids submitted for prime funded opportunities, including

1819

~~opportunities, including~~ both new and re-compete contracts. Submittals do not include values of bids submitted for ID/IQ contracts or bids submitted as a subcontractor. As a result of this activity, we had approximately $23.26 billion of funded proposals awaiting award decision at ~~December~~March 31, ~~2014~~2015.

Our total backlog as of ~~December~~March 31, ~~2014~~2015 includes orders under contracts that, in some cases, extend for several years, with the latest expiring during calendar year ~~2021~~2023. Congress often appropriates funds for our customers on a yearly basis, even though the corresponding contract with us may call for performance that is expected to take a number of years. As a result, contracts typically are only partially funded at any point during their term with further funding dependent on Congress making subsequent appropriations and the procuring agency allocating funding to the contract. The U.S. government may cancel any contract at any time. Most of our contracts have cancellation terms that would permit us to recover all or a portion of our incurred costs, termination costs, and potentially fees for work performed.

As of ~~December~~March 31, ~~2014~~2015, we expect to recognize approximately 2529% of our backlog as revenue within the next twelve months.

Contract Mix

When contracting with our customers, we typically enter into one of three basic types of contracts: cost-plus-fee, time-and-materials, and fixed-price.


•	Cost-plus-fee contracts. Cost-plus-fee contracts provide for reimbursement of allowable costs and the payment of a fee, which is our profit. In addition, some cost-plus-fee contracts provide for an award fee or incentive fee for meeting the requirements of the contract.


•	Time-and-materials contracts. Time-and-materials contracts provide for a fixed hourly rate for each direct labor hour expended plus reimbursement of allowable material costs and out-of-pocket expenses.

•

Fixed-price contracts. Fixed-price contracts provide for a pre-determined fixed price for specified products and/or services. Fixed-price-level-of-effort contracts are similar to time-and-materials contracts except they require a specified level of effort over a stated period of time. To the extent our actual costs vary from the estimates upon which the price of the fixed-price contract was negotiated, we will generate more or less than the anticipated amount of profit or could incur a loss.

Each of these contract types has unique characteristics. From time to time, contracts may be issued that are a combination or hybrid of contract types. Cost-plus-fee contracts generally subject us to lower risk. They also can include award fees or incentive fees under which the customer may make additional payments based on our performance. However, not all costs are reimbursed under these types of contracts, and the government carefully reviews the costs we charge. In addition, negotiated base fees are generally lower than projected profits on fixed-price or time-and-materials contracts, consistent with our lower risk. Under time-and-materials contracts, including our fixed-price-level-of effort contracts, we are also generally subject to lower risk; however, our profit may vary if actual labor hour costs vary significantly from the negotiated rates. Fixed-price contracts typically involve the highest risk and, as a result, typically have higher fee levels. Fixed-price contracts require that we absorb cost overruns, should they occur.

The following table summarizes our historical contract mix, measured as a percentage of total revenue, for the periods indicated.

	Three months ended December 31,				Six months ended December 31,
	Three months ended March 31,				Nine months ended March 31,
	2013		2014		2013		2014
	2014		2015		2014		2015
Cost-plus-fee	3229	%	2728	%	31	%	27	%
Time-and-materials	3438	%	3938	%	3435	%	39	%
Fixed-price (a)	3433	%	34	%	3534	%	34	%

(a) Includes approximately 3% of the revenue earned on fixed-price-level-of-effort contracts for the fiscal 2014 and 2015 periods.

Labor Utilization

Because most of our revenue and profit is derived from services delivered by our employees, our ability to hire new employees and retain and deploy them is critical to our success. We define direct labor utilization as the ratio of labor expense recorded on customer engagements to total labor expense. We include every working employee in the computation and exclude leave taken, such as vacation time. As of March 31, 2015, we had approximately 5,400 employees. Direct labor utilization was

1920

~~leave taken, such as vacation time. As of December 31, 2014, we had approximately 5,400 employees. Direct labor utilization was~~ 81.~~8% and 81.~~6% for both the three and ~~six~~nine months ended ~~December~~March 31, ~~2014~~2015, ~~respectively,~~ compared to 8281.09% and 81.14% in the same periods of the prior year. In assessing labor utilization, management focuses on maintaining a high utilization rate to maximize profitability while ensuring time and resources are also spent strategically growing and managing the business. Labor incurred in the performance of our contracts is included in cost of services and all other labor costs incurred are included in selling, general and administrative expenses.

Days Sales Outstanding

Days sales outstanding, or DSO, is a measure of how efficiently we manage the billing and collection of accounts receivable, our most significant working capital component. From time to time we may offer discounts to our customers for early payment. We also utilize an accounts receivable factoring facility to accelerate cash flow and lower our DSO. We calculate DSO by dividing accounts receivable at the end of each quarter, net of billings in excess of revenue, by revenue per day for the period. Revenue per day for a quarter is determined by dividing total revenue by 90 days, adjusted for partial periods related to any acquisitions and divestitures. DSO was 5753 days as of ~~December~~March 31, ~~2014~~2015 and 6663 days as of ~~December~~March 31, ~~2013~~2014.

Seasonality

Certain aspects of our operations are influenced by the federal government’s October-to-September fiscal year. The timing of contract awards, the availability of funding from the customer and the incurrence of contract costs are the primary drivers of our revenue recognition and may all be affected by the government’s fiscal year. Additionally, our quarterly results are impacted by the number of working days in a given quarter. There are generally fewer working days for our employees to generate revenue in the first and second quarters of our fiscal year because our employees usually take relatively more leave for vacations and holidays, which leads to lower revenue and profitability in those quarters. Also, we typically give annual raises to our employees in the first half of our fiscal year, while the billing rates on our time-and-materials contracts typically escalate gradually, causing the profitability on these contracts to increase over the course of our fiscal year.

Summary of Financial Results

	Three months ended December 31,						Six months ended December 31,
	Three months ended March 31,						Nine months ended March 31,
	2013			2014			2013			2014
	2014			2015			2014			2015
Revenue	$	~~333~~355,~~713~~930		$	~~342~~349,~~018~~708		$	~~683~~1,~~536~~039,465		$	~~680~~1,~~633~~030,341
Operating costs and expenses:
Cost of services	~~260~~276,~~050~~319			~~264~~266,~~101~~861			~~524~~800,~~187~~506			~~519~~786,~~864~~725
Selling, general and administrative	4050,~~207~~004			4146,~~352~~364			85135,~~748~~751			86132,~~282~~646
Depreciation and amortization of property and equipment	2,~~323~~248			12,~~998~~096			47,~~908~~156			46,~~074~~170
Amortization of intangible assets	18,064			14,~~350~~351			3654,~~584~~647			2943,~~122~~473
Gain on the sale of a portion of the Health & Civil business	—			—			(1,564		)	—
Total operating costs and expenses	~~320~~346,~~644~~635			~~321~~329,~~801~~672			~~649~~996,~~863~~496			~~639~~969,~~342~~014
Operating income	139,~~069~~295			20,~~217~~036			3342,~~673~~969			4161,~~291~~327
Interest expense	(2625,~~356~~714		)	(26,~~566~~222		)	(5278,~~527~~241		)	(5380,~~840~~062		)
Interest income	249			911			3443			2334
Loss before income taxes	(1316,~~263~~410		)	(6,~~340~~175		)	(1835,~~820~~229		)	(1218,~~526~~701		)
Benefit from income taxes	(57,~~095~~122		)	(~~297~~3,516		)	(714,~~111~~233		)	(25,~~325~~841		)
Net loss	$	(89,~~168~~288	)	$	(62,~~043~~659	)	$	(1120,~~709~~996	)	$	(1012,~~201~~860	)

	Six months ended December 31,
	2013		2014
Net cash provided by operating activities	$	48,105	$	2,276
Net cash provided by (used in) investing activities	731		(4,453		)
Net cash used in financing activities	—		(10,833		)
Net increase (decrease) in cash and cash equivalents	$	48,836	$	(13,010	)

Items Affecting the Comparability of Our Operating Results



	Nine months ended March 31,
	2014			2015

Net cash provided by operating activities	$	50,274		$	51,571
Net cash used in investing activities	(1,476		)	(6,126		)
Net cash used in financing activities	—			(10,833		)
Net increase in cash and cash equivalents	$	48,798		$	34,612

We define Adjusted EBITDA as GAAP net loss plus (i) provision for (benefit from) income taxes, (ii) net interest (income) expense, (iii) depreciation and amortization of property and equipment, and (iv) amortization of intangible assets, or EBITDA, adjusted to exclude certain items that do not relate directly to our ongoing operations or which are non-cash in nature. Adjusted EBITDA, or Consolidated EBITDA as is defined in the credit agreement, as presented in the table below is used to determine our compliance with certain covenants contained in our credit agreement. We also use Adjusted EBITDA as a supplemental measure in the evaluation of our business because it provides a meaningful measure of operational performance by eliminating the effects of period-to-period changes in taxes and interest expense, among other things.

Adjusted EBITDA decreased in the three, six and twelve months ended December 31, 2014 as compared to the same periods in the prior year. Amongst the three periods, the twelve-month period represents the largest decline as compared to the corresponding prior year period due to the completion of the Federal Deposit Insurance Corporation, or FDIC, contract in April 2014. Adjusted EBITDA margin for the three, six and twelve months ended December 31, 2014 was 11.2%, 12.3% and 12.9%, respectively, compared to 11.7%, 12.3% and 13.1% for the prior year periods.

	Three months ended December 31,						Six months ended December 31,
	2013			2014			2013			2014
Loss from continuing operations	$	(8,168	)	$	(6,043	)	$	(11,709	)	$	(10,201	)
Benefit from income taxes	(5,095		)	(297		)	(7,111		)	(2,325		)
Interest expense, net	26,332			26,557			52,493			53,817
Depreciation and amortization of property and equipment	2,711			2,304			5,619			4,739
Amortization of intangible assets	18,064			14,350			36,584			29,122
Stock compensation	796			563			2,130			2,786
Severance	1,196			152			1,151			499
Facility exit charge	392			(1,906		)	503			(551		)
Other, net	704			1,720			1,500			2,945
Gain on the sale of a portion of our Health & Civil business	—			—			(1,564		)	—
Subtotal - Adjusted EBITDA before certain items	36,932			37,400			79,596			80,831
EBITDA impact of cost savings	2,103			1,039			4,794			2,767
Adjusted EBITDA	$	39,035		$	38,439		$	84,390		$	83,598

	Twelve months ended December 31,
	2013			2014
Loss from continuing operations	$	(316,069	)	$	(22,654	)
Benefit from income taxes	(60,039		)	(11,500		)
Interest expense, net	102,526			105,450
Depreciation and amortization of property and equipment	12,065			9,844
Amortization of intangible assets	81,008			65,249
Stock compensation	2,932			4,002
Severance	1,639			827
Facility exit charge	3,033			11,756
Other, net	3,914			5,452
Impairment of goodwill and other assets	345,753			—
Gain on the sale of a portion of our Health & Civil business	(1,564		)	—
Subtotal - Adjusted EBITDA before certain items	175,198			168,426
EBITDA impact of cost savings	11,785			9,650
Adjusted EBITDA	$	186,983		$	178,076

Items Affecting the Comparability of Our Operating Results

~~The~~We ~~following~~define ~~items~~Adjusted ~~affect~~EBITDA ~~the~~as ~~comparability~~GAAP ofnet ~~our~~loss plus (i) provision for (benefit from) income taxes, (ii) net ~~loss~~interest ~~period-over-period~~(income) expense, (iii) depreciation and ~~therefore~~amortization of property and equipment, ~~have~~and ~~been~~(iv) amortization of intangible assets, or EBITDA, adjusted to exclude certain items that do not relate directly to our ongoing operations or which are non-cash in ~~arriving~~nature atand to include the pro forma impact of acquisitions and cost savings initiatives. Adjusted EBITDA:, or Consolidated EBITDA as is defined in the credit agreement, and as presented in the table below is used to determine our compliance with incurrence covenants contained in our credit agreement. We also use Adjusted EBITDA as a supplemental measure in the evaluation of our business because it provides a meaningful measure of operational performance by eliminating the effects of period-to-period changes in taxes and interest expense, among other things.

•Adjusted ~~Stock~~EBITDA ~~compensation~~increased ~~expense~~in ~~related~~the three, nine and twelve months ended March 31, 2015 as compared to the ~~stock~~same ~~incentive~~periods ~~plans~~in the prior year. The ~~charges~~increase ~~are~~was ~~included~~primarily indue ~~SG&A~~to ~~expenses~~the inpro forma impact of the ~~condensed~~acquisition ~~consolidated~~of ~~statements~~substantially all of ~~operations~~the Government Services business from Qbase LLC in April 2015 and cost savings initiatives. Adjusted EBITDA margin, excluding the effect of acquisitions, for the three, nine and twelve months ended March 31, 2015 was 12.6%, 12.7% and 13.2%, respectively, compared to 11.4%, 12.2% and 12.4% for the prior year periods.

• Severance charges incurred to primarily reduce our indirect labor force. The gross charges are included in SG&A expenses in the condensed consolidated statements of operations.



	Three months ended March 31,						Nine months ended March 31,
	2014			2015			2014			2015

Loss from continuing operations	$	(9,288	)	$	(2,659	)	$	(20,996	)	$	(12,860	)
Benefit from income taxes	(7,122		)	(3,516		)	(14,233		)	(5,841		)
Interest expense, net	25,705			26,211			78,198			80,028
Depreciation and amortization of property and equipment	2,659			2,225			8,279			6,964
Amortization of intangible assets	18,064			14,351			54,647			43,473
Stock compensation	435			633			2,565			3,419
Severance	162			171			1,313			670
Facility exit charge	8,053			3,855			8,556			3,304
Other, net	835			1,716			2,335			4,661
Gain on the sale of a portion of our Health & Civil business	—			—			(1,564		)	—
Subtotal - Adjusted EBITDA before certain items	39,503			42,987			119,100			123,818
EBITDA impact of acquisitions	—			3,021			—			10,183
EBITDA impact of cost savings	1,118			1,236			8,101			6,662
Adjusted EBITDA	$	40,621		$	47,244		$	127,201		$	140,663

• Facility exit charges related to the exit of underutilized space in certain of our leased facilities. The charges are included in SG&A expenses in the condensed consolidated statements of operations.

• Certain other items including the following:

	Three months ended December 31,						Six months ended December 31,
	Twelve months ended March 31,
	2013			2014			2013		2014
	2014			2015
Signing and retention bonuses of certain executive officers	$	—		$	—		$	—	$	—
Loss from continuing operations	$	(324,163	)	$	(16,024	)
Management fees	438			438			875		875
Benefit from income taxes	(62,944		)	(7,894		)
Merger and acquisition costs	230			170			477		317
Interest expense, net	103,344			105,955
Loss on sale of receivables	—			245			—		477
Depreciation and amortization of property and equipment	11,431			9,410
Facility opening costs	—			482			—		482
Amortization of intangible assets	76,868			61,536
Other	36			385			148		794
Stock compensation	2,935			4,200
Other, net	$	704		$	1,720		$	1,500	$	2,945
Severance	1,759			836
	Twelve months ended December 31,
Facility exit charge	8,377			7,558
	2013			2014
Other, net	3,523			6,332
Signing and retention bonuses of certain executive officers	$	84		$	100
Impairment of goodwill and other assets	345,753			—
Management fees	1,750			1,750
Gain on the sale of a portion of our Health & Civil business	(1,564		)	—
Merger and acquisition costs	1,480			725
Subtotal - Adjusted EBITDA before certain items	165,319			171,909
Loss on sale of receivables	—			887
EBITDA impact of acquisitions	—			12,726
Facility opening costs	—			482
EBITDA impact of cost savings	12,025			10,605
Other	600			1,508
Adjusted EBITDA	$	177,344		$	195,240
Other, net	$	3,914		$	5,452

The following items affect the comparability of our net loss period-over-period and, therefore, have been adjusted in arriving at Adjusted EBITDA:


•	Stock compensation expense related to the stock incentive plans. The charges are included in SG&A in the condensed consolidated statements of operations.


•	Severance charges incurred to primarily reduce our indirect labor force. The gross charges are included in SG&A in the condensed consolidated statements of operations.


•	Facility exit charges related to the exit of underutilized space in certain of our leased facilities. The charges are included in SG&A in the condensed consolidated statements of operations.


•	Certain other items including the following:



	Three months ended March 31,				Nine months ended March 31,
	2014		2015		2014		2015

Signing and retention bonuses of certain executive officers	$	—	$	—	$	—	$	—
Management fees	438		438		1,313		1,313
Merger and acquisition costs	179		148		656		465
Loss on sale of receivables	162		237		162		714
Facility opening costs	—		720		—		1,202
Other	56		173		204		967
Other, net	$	835	$	1,716	$	2,335	$	4,661

	Twelve months ended March 31,
	2014		2015

Signing and retention bonuses of certain executive officers	$	84	$	100
Management fees	1,750		1,750
Merger and acquisition costs	933		695
Loss on sale of receivables	162		962
Facility opening costs	—		1,202
Other	594		1,623
Other, net	$	3,523	$	6,332


•	Impairment of goodwill and trade names as a result of the annual impairment analysis for fiscal 2013.


•	Gain on the sale of a portion of our Health & Civil business in the first quarter of fiscal 2014.

• AsThe ~~defined~~acquisition ~~in our credit agreement, cost savings represent the EBITDA impact~~ of ~~quantifiable~~substantially ~~run-rate~~all ~~cost savings for actions taken or expected to be taken within 12 months~~ of the ~~reporting~~Government ~~date~~Services asbusiness iffrom ~~they~~Qbase ~~had~~LLC ~~been~~in ~~realized~~April ~~on the first day of the relevant period~~2015. ~~Specifically,~~In ~~for~~calculating ~~the~~Adjusted ~~periods presented~~EBITDA, ~~the~~we ~~cost~~added ~~savings adjustment represents~~ the estimated EBITDA impact of ~~actions taken to exit underutilized space in certain of our leased facilities~~acquisitions, ~~savings~~as ~~associated~~if ~~with~~the ~~certain~~business ~~fringe~~had ~~benefit~~been ~~changes~~acquired ~~and~~on ~~cost~~the ~~savings~~first ~~achieved~~day ~~from~~of ~~specific actions to improve~~ the ~~profitability~~respective ofreporting ~~our contract base~~periods.

•

As defined in our credit agreement, cost savings represent the EBITDA impact of quantifiable run-rate cost savings for actions taken or expected to be taken within 12 months of the reporting date as if they had been realized on the first day of the relevant period. Specifically, for the periods presented, the cost savings adjustment represents the estimated EBITDA impact of actions taken to exit underutilized space in certain of our leased facilities, savings associated with certain fringe benefit changes and cost savings associated with actions to improve the profitability of our contract base.

The impact of these items on our net loss is shown in the table above. We present Adjusted EBITDA as an additional measure of our core business performance period over period. Adjustments to net loss result in a non-GAAP measure; however, we believe adjustment of the items above is useful as they are considered outside the normal course of our operations and obscure the comparability of performance period over period.

Results of Operations

Revenue

Revenue ~~increased~~decreased 21.57% to $~~342~~349.07 million in the three months ended ~~December~~March 31, ~~2014~~2015 from $~~333~~355.79 million in the three months ended ~~December~~March 31, ~~2013~~2014. This decrease was impacted by the completion of the FDIC contract in April 2014. Revenue decreased 0.49% to $~~680~~1,030.63 million in the ~~six~~nine months ended ~~December~~March 31, ~~2014~~2015 from $~~683~~1,039.5 million in the ~~six~~nine months ended ~~December~~March 31, ~~2013~~2014. ~~Revenue~~This ~~variances~~decrease ~~during~~was ~~these periods were~~ impacted by the completion of the FDIC contract in April 2014 and the federal government shutdown in October 2013. Excluding these impacts, revenue increased 52.87% and 43.27% from the three and ~~six~~nine months ended ~~December~~March 31, ~~2013~~2014 as compared to the three and ~~six~~nine months ended ~~December~~March 31, ~~2014~~2015, respectively. This increase was driven by an acceleration in new business wins and deceleration in contract erosion.

2425

Operating Costs and Expenses

Operating costs and expenses consisted of the following for the periods presented (dollars in thousands):

	Three months ended December 31,
	Three months ended March 31,
	2013			2014			% Change
	2014			2015			% Change
Cost of services	$	~~260~~276,~~050~~319		$	~~264~~266,~~101~~861		1(3.64	)%
Selling, general and administrative	4050,~~207~~004			4146,~~352~~364			2(7.83	)%
Depreciation and amortization of property and equipment	2,~~323~~248			12,~~998~~096			(146.08	)%
Amortization of intangible assets	18,064			14,~~350~~351			(20.6	)%
	(as a percentage of revenue)
Cost of services	77.96		%	7776.23		%
Selling, general and administrative	1214.0		%	1213.13		%
Depreciation and amortization of property and equipment	0.76		%	0.6		%
Amortization of intangible assets	5.41		%	4.21		%
	Six months ended December 31,
	Nine months ended March 31,
	2013			2014			% Change
	2014			2015			% Change
Cost of services	$	~~524~~800,~~187~~506		$	~~519~~786,~~864~~725		(01.87	)%
Selling, general and administrative	85135,~~748~~751			86132,~~282~~646			0(2.63	)%
Depreciation and amortization of property and equipment	47,~~908~~156			46,~~074~~170			(1713.08	)%
Amortization of intangible assets	3654,~~584~~647			2943,~~122~~473			(20.4	)%
Gain on the sale of a portion of the Health & Civil business	(1,564		)	—			NMF
	(as a percentage of revenue)
Cost of services	7677.70		%	76.4		%
Selling, general and administrative	1213.51		%	12.79		%
Depreciation and amortization of property and equipment	0.7		%	0.6		%
Amortization of intangible assets	5.43		%	4.32		%
Gain on the sale of a portion of the Health & Civil business	(0.2		)%	—

NMF = Not meaningful

2526

Cost of services consisted of the following for the periods presented (dollars in thousands):

	Three Months Ended December 31, 2013		% of total		Three Months Ended December 31, 2014		% of total
	Three Months Ended March 31, 2014		% of total		Three Months Ended March 31, 2015		% of total
Direct labor and related overhead	$	~~128~~136,~~742~~671	49.5	%	$	~~132~~135,~~619~~618	50.28	%
Subcontractor labor	8090,~~320~~543		3032.98	%	8589,~~606~~195		3233.4	%
Materials and other reimbursable costs	5049,~~988~~105		1917.68	%	4542,~~876~~048		1715.48	%
Total cost of services	$	~~260~~276,~~050~~319			$	~~264~~266,~~101~~861
	Six Months Ended December 31, 2013		% of total		Six Months Ended December 31, 2014		% of total
	Nine Months Ended March 31, 2014		% of total		Nine Months Ended March 31, 2015		% of total
Direct labor and related overhead	$	~~263~~399,~~018~~689	5049.29	%	$	~~262~~398,~~703~~321	50.6	%
Subcontractor labor	~~166~~257,~~891~~435		3132.82	%	~~171~~260,~~725~~920		33.02	%
Materials and other reimbursable costs	94143,~~278~~382		1817.09	%	85127,~~436~~484		16.42	%
Total cost of services	$	~~524~~800,~~187~~506			$	~~519~~786,~~864~~725

Cost of services ~~increased~~decreased $49.15 million in the three months ended ~~December~~March 31, ~~2014~~2015 compared to the three months ended ~~December~~March 31, ~~2013~~2014 and decreased $413.38 million in the ~~six~~nine months ended ~~December~~March 31, ~~2014~~2015 compared to the same period of the prior year. ~~The~~ Cost ~~change~~of services decreased in ~~costs~~the ofthree ~~services~~and isnine ~~consistent~~months ~~with~~ended March 31, 2015 compared to the ~~change~~same periods in ~~revenue~~the prior year primarily due to lower materials and reimbursable costs as a result of the loss of the FDIC contract. As a percentage of revenue, cost of services ~~remained~~improved ~~consistent~~slightly in the three and ~~six~~nine months ended ~~December~~March 31, ~~2014~~2015 compared to the three and ~~six~~nine months ended ~~December~~March 31, ~~2013.~~2014 primarily due to a more profitable contract mix.

Cost of services as a percentage of revenue varies from period to period depending on the mix of direct labor, subcontractor labor, and materials and other reimbursable costs. In periods where we have more materials and other reimbursable content, our costs of services as a percentage of revenue will be higher. We seek to optimize our labor content in performance of our contracts since we typically generate greater gross margin from our labor services, particularly from services that our employees provide, compared with other reimbursable items.

SG&A ~~expenses~~decreased ~~increased~~ $13.16 million in the three months ended ~~December~~March 31, ~~2014~~2015 compared to the three months ended ~~December~~March 31, ~~2013~~2014 and $03.51 million in the ~~six~~nine months ended ~~December~~March 31, ~~2014~~2015 compared to the same period of the prior year. Excluding the impact of the facility exit charges, stock compensation expense, severance charges to reduce our indirect labor force, officer compensation and other non-recurring costs, which are all discussed in greater detail in the section listed “Items Affecting the Comparability of Our Operating Results,” SG&A ~~expenses~~decreased ~~increased~~ approximately $40.28 million and $0.53 million in the three and ~~six~~nine months ended ~~December~~March 31, ~~2014~~2015 compared to the comparable periods of the prior year. ~~Excluding~~as ~~the impact of the federal government shutdown in October 2013, the increase is primarily~~ a result of ~~higher~~cost ~~bid~~saving ~~and proposal costs and recruiting~~ efforts ~~to staff new business wins and existing contract expansion~~.

Depreciation and amortization of property and equipment decreased $0.2 million in the three ~~and six~~ months ended ~~December~~March 31, ~~2014~~2015 compared to the three months ended March 31, 2014 and ~~six~~$1.0 million in the nine months ended ~~December~~March 31, ~~2013~~2015 compared to the same period of the prior year, primarily as a result of disposing of assets in darkened facilities and delaying replacement of certain fully depreciated assets.

Amortization of intangible assets decreased $3.7 million in the three ~~and six~~ months ended ~~December~~March 31, ~~2014~~2015 as compared to the three months ended March 31, 2014 and ~~six~~$11.2 million in the nine months ended ~~December~~March 31, ~~2013~~2015 ascompared ~~amortization~~to isthe ~~recorded~~same onperiod anof the prior year, primarily as a result of accelerated ~~basis~~recognition ~~based~~of onamortization due to the expected benefits of the assets.

~~The~~We ~~Company~~ recorded a gain on the sale of a portion of the Health & Civil business of $1.6 million recognized on the sale of six contracts from the Health & Civil group during the first quarter of fiscal 2014. For details, see Note 1 to our condensed consolidated financial statements as of and for the fiscal quarter ended ~~December~~March 31, ~~2014~~2015 included in this quarterly report on Form 10-Q.

2627

Interest

	Three months ended December 31,						Six months ended December 31,
	Three months ended March 31,						Nine months ended March 31,
	2013			2014			2013			2014
	2014			2015			2014			2015
Interest expense	$	(2625,~~356~~714	)	$	(26,~~566~~222	)	$	(5278,~~527~~241	)	$	(5380,~~840~~062	)
Interest income	249			911			3443			2334
Interest, net	$	(2625,~~332~~705	)	$	(26,~~557~~211	)	$	(5278,~~493~~198	)	$	(5380,~~817~~028	)

Interest expense increased in the three and ~~six~~nine months ended ~~December~~March 31, ~~2014~~2015 by $0.25 million and $1.38 million, respectively, compared to the comparable prior year periods primarily due to an increase of the fixed rates on our interest rate swaps. Interest expense for the three and ~~six~~nine months ended ~~December~~March 31, ~~2014~~2015 includes amortization of original issue discount and debt issuance costs of $1.6 million and $35.63 million, respectively, compared to $1.8 million and $35.76 million in the comparable prior year periods. We manage our exposure to interest rate movements through the use of interest rate swap agreements. As of ~~December~~March 31, ~~2014~~2015, we had fixed the interest rate on all but $164.2 million of our outstanding total debt of $1.1 billion.

Income Taxes

Our effective tax rate for the ~~six~~nine months ended ~~December~~March 31, ~~2013~~2014 and ~~2014~~2015 was a tax benefit of 3740.84% and 1831.62%, respectively. Our year to date fiscal 2014 effective tax rate was ~~lower~~higher than the statutory income tax rate primarily due to ~~non-deductible~~federal ~~permanent~~tax ~~items~~credits. Our year to date fiscal 2015 tax rate was lower than the statutory income tax rate primarily as a result of adjusting tax benefits recognized previously in the financial statements and prior year tax returns.

Liquidity and Capital Resources

Our primary capital needs are to finance the costs of operations, pending the billing and collection of accounts receivable and to make acquisitions. Our working capital (current assets minus current liabilities) as of ~~December~~March 31, ~~2014~~2015 was $82128.37 million compared to $76.0 million as of June 30, 2014. As of ~~December~~March 31, ~~2014~~2015, our total unrestricted cash and cash equivalents was $95143.85 million and our total outstanding debt was approximately $1.1 billion, excluding unamortized discount.

	Six months ended December 31,
	Nine months ended March 31,
	2013			2014
	2014			2015
Net cash provided by operating activities	$	4850,~~105~~274		$	251,~~276~~571
Net cash provided by (used in) investing activities	731			(4,453		)
Net cash used in investing activities	(1,476		)	(6,126		)
Net cash used in financing activities	—			(10,833		)
Net increase (decrease) in cash and cash equivalents	$	48,836		$	(13,010	)
Net increase in cash and cash equivalents	$	48,798		$	34,612

Cash Flow

Accounts receivable represent our largest working capital requirement. We bill the majority of our customers monthly after services are rendered. Our operating cash flow is primarily affected by the overall profitability of our contracts, our ability to invoice and collect from our customers in a timely manner, and the timing of vendor and tax payments.

Net cash provided by operating activities was $4850.13 million and $251.36 million in the ~~six~~nine months ended ~~December~~March 31, ~~2013~~2014 and ~~2014~~2015, respectively. In the ~~six~~nine months ended ~~December~~March 31, ~~2014~~2015, the ~~decrease~~increase in cash provided by operating activities was primarily due to ~~timing~~more offavorable ~~interest~~operating ~~payments,~~results ~~vendor payments~~ and the ~~collection~~timing of ~~receivable~~interest ~~balances~~payments.

Net cash ~~provided~~used byin investing activities was $01.75 million ~~for the six months ended December 31, 2013~~ and ~~net cash used in investing activities was~~ $46.51 million infor the ~~six~~nine months ended ~~December~~March 31, 2014 and March 31, 2015, respectively. In the ~~six~~nine months ended ~~December~~March 31, ~~2014~~2015, net cash used in investing activities represented $46.51 million of capital expenditures. In the ~~six~~nine months ended ~~December~~March 31, ~~2013~~2014, net cash ~~provided~~used byin investing activities was driven by capital expenditures of $7.0 million partially offset by $5.5 million from the sale of a portion of the Health & Civil business ~~offset partially by capital expenditures of $4~~.~~8 million.~~

Net cash used in financing activities was zero and $10.8 million in the ~~six~~nine months ended ~~December~~March 31, ~~2013~~2014 and ~~2014~~2015, respectively. Borrowings on our revolving credit facility during the ~~six~~same nine months ended ~~December~~March 31, ~~2013~~2014 of $100.0 million were repaid during the ~~six~~same nine months. Net cash used in financing activities in fiscal 2015 related to repayments on our Term Loan B Facility.

2728

Indebtedness

In connection with the Transaction, we entered into senior secured credit facilities consisting of an $875 million term loan B facility, or Term Loan B Facility, due July 2018, and a $100 million senior secured revolving credit facility, or the Revolver, due July 2016, and together with the Term Loan B Facility, the Senior Secured Credit Facilities. Additionally, we issued $400 million aggregate principal amount of senior notes, or Notes, due October 1, 2019.

Our Term Loan B Facility requires annual payments equal to 50% of ECF based upon achievement of a net senior secured leverage ratio, or NSSLR, between 2.75x and 3.5x. The required annual payments adjust to 75% of ECF when NSSLR is greater than 3.5x, 25% of ECF when NSSLR is between 2x and 2.75x, and zero if ~~NSSRL~~NSSLR is less than 2x. Any required ECF payments are due in October each year, subject to acceptance by the lenders.We are required to meet the NSSLR covenant quarterly if any revolving loan, swing-line loan or letter of credit is outstanding on the last day of the quarter. As of March 31, 2015, we had no outstanding letters of credit or borrowings under our Revolver. The ratio is calculated as the consolidated net secured indebtedness as of the last day of the quarter (defined as consolidated net secured debt less any cash and permitted investments) to the preceding four quarters’ consolidated EBITDA (as defined in the Credit Agreement). As of March 31, 2015, our net senior secured leverage ratio was 2.9x. We were in compliance with all of our covenants as of March 31, 2015.

We are required to meet the NSSLR covenant quarterly if any revolving loan, swing-line loan or letter of credit is outstanding on the last day of the quarter. As of December 31, 2014, we had no outstanding letters of credit or borrowings under our Revolver. The ratio is calculated as the consolidated net secured indebtedness as of the last day of the quarter (defined as consolidated net secured debt less any cash and permitted investments) to the preceding four quarters’ consolidated EBITDA (as defined in the Credit Agreement). The required ratio decreases over time from less than or equal to 4.75x as of December 31, 2014 to less than or equal to 4.5x as of June 30, 2016. As of December 31, 2014, our net senior secured leverage ratio was 3.2x. We were in compliance with all of our covenants as of December 31, 2014.

We repaid $140.0 million of our Term Loan B Facility in fiscal 2012, which satisfied all of the required quarterly principal payments for the term of the loan and satisfied our required ECF principal payments for fiscal 2012. We repaid $20.0 million of our Term Loan B Facility in fiscal 2013, which satisfied our required ECF principal payments for fiscal 2013. The fiscal 2014 ECF requirement was $61.5 million, of which we repaid $40.0 million during fiscal 2014. The remainder was tendered as payment in October 2014, of which $10.6 million was declined by the lenders and returned to the Company, as permitted by the facility.

The $400.0 million of Notes bear interest at a rate of 11% per annum and mature on October 1, 2019. Interest on the Notes is payable semi-annually. The Notes are redeemable in whole or in part, at our option, at varying redemption prices that generally include premiums.

The Senior Secured Credit Facilities and the Notes are guaranteed by all of our wholly-owned subsidiaries. The Senior Secured Credit Facilities are also guaranteed by Sterling Parent. The guarantees are full and unconditional and joint and several. Each of our subsidiary guarantors are 100% owned and have no independent assets or operations.

Capital Requirements

We believe the capital resources available to us under the Revolver portion of our Senior Secured Credit Facilities and cash from our operations are adequate to fund our normal working capital needs as well as our capital expenditure requirements, which are expected to be approximately 0.87% of revenue, for at least the next twelve months.

Income Taxes

The Transaction accelerated the recognition of expense for stock options and restricted stock, creating a tax deduction of approximately $80.0 million in fiscal 2012. As a result of net operating loss carryforwards resulting primarily from this stock compensation deduction, as well as Transaction costs and tax-deductible interest expense, we do not expect to make any material U.S. federal income tax payments until fiscal ~~2017~~2016.

Accounts Receivable Factoring

During fiscal 2014, we entered into an accounts receivable purchase agreement under which we sell certain accounts receivable to a third party, or the Factor, without recourse to the Company. The Factor initially pays the Company 90% of the receivable and the remaining price is deferred and based on the amount the Factor receives from our customer. The structure of the transaction provides for a true sale, on a revolving basis, of the receivables transferred. Accordingly, upon transfer of the receivable to the Factor, the receivable is removed from our consolidated balance sheet, a loss on the sale is recorded and the deferred price is an account receivable until it is collected. The balance of the sold receivables may not exceed $50 million at any time. During the three and ~~six~~nine months ended ~~December~~March 31, 2014, we sold ~~approximately~~$50.0 million of receivables and recognized a related loss of $~~102~~0.62 million in selling, general and administrative expenses. During the three and nine months ended March 31, 2015, we sold $~~188~~103.74 million and $292.1 million of receivables, respectively, and recognized a related loss of $0.2 million and $0.57 million in selling, general and administrative expenses for the same periods, respectively. As of ~~December~~March 31, ~~2014~~2015, the balance of the sold receivables was ~~approximately~~ $3129.85 million, and the related deferred price was ~~approximately~~ $3.12 million. The factoring agreement resulted in accelerated cash flow to ~~the Company~~us.

2829

Off-Balance Sheet Arrangements

As of ~~December~~March 31, ~~2014~~2015, ~~other than operating leases,~~ we had no material off-balance sheet arrangements, including retained or contingent interests in assets transferred to unconsolidated entities; derivative instruments indexed to our stock and classified in stockholder’s equity on the condensed consolidated balance sheet; or variable interests in entities that provide us with financing, liquidity, market risk or credit risk support or engage with us in leasing, hedging or research and development services. We utilize interest rate derivatives to add stability to interest expense and to manage our exposure to interest rate movements.

For further discussion of our derivative instruments and hedging activities see Item 3 below and Note 6 to our condensed consolidated financial statements as of and for the period ended ~~December~~March 31, ~~2014~~2015 included in this quarterly report on Form 10-Q.

Description of Critical Accounting Policies and Estimates

The preparation of our financial statements in accordance with GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, as well as the disclosure of contingent assets and liabilities. These estimates are based on our historical experience and various other factors that are deemed reasonable at the time the estimates are made. Actual results may differ significantly from these estimates under different assumptions or conditions. We re-evaluate these estimates quarterly and test goodwill and trade names for impairment at least annually during the fourth quarter as of April 1. We believe the critical accounting policies requiring significant estimates and judgments are revenue recognition, accounting for acquisitions, including the identification of intangible assets and the ongoing impairment assessments of goodwill and intangible assets, accounting for stock compensation expense and income taxes. If any of these estimates or judgments proves to be inaccurate, our results could be materially affected in the future.

For a full discussion of our critical accounting policies, refer to the "Description of Critical Accounting Policies and Estimates" section included in our annual report on Form 10-K filed with the Securities and Exchange Commission on August 8, 2014.

Recent Accounting Pronouncements

In May 2014, the ~~FASB~~Financial Accounting Standards Board issued Accounting Standard Update, or ASU 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. This ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. ~~The~~This ~~new~~ASU standard is effective for our fiscal 2018. Early application is not permitted. ~~The~~This ~~standard~~ASU permits the use of either the retrospective or cumulative effect transition method. We are evaluating the ~~effect~~methods ~~that~~of ~~ASU~~adoption ~~2014-09~~allowed ~~will~~by ~~have~~the onASU ~~our consolidated financial statements~~ and ~~related~~the ~~disclosures.~~effect Wethat ~~have~~it ~~not~~is ~~yet~~expected ~~selected~~to ~~a transition method nor~~ have ~~we determined the effect of the standard~~ on our ~~ongoing~~consolidated financial ~~reporting~~statements.

In April 2015, the Financial Accounting Standards Board issued ASU 2015-03, Interest - Imputation of Interest, which requires the debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with the presentation of debt discounts. Adoption of this ASU is not expected to have an impact on our consolidated financial position, results of operations, or cash flows.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are subject to market risk, primarily relating to potential losses arising from adverse changes in interest rates. For a further discussion of market risks we may encounter, refer to our “Risk Factors” section included in our Form 10-K filed with the Securities and Exchange Commission on August 8, 2014.

Interest Rate Risk

Borrowings under our senior secured credit facilities are at variable interest rates and expose us to interest rate risk. However, we manage our exposure to interest rate movements through the use of interest rate swap agreements. The interest rate swap derivatives decrease over time to a notional value of $475.0 million upon maturity of the swaps in July 2016. As of ~~December~~March 31, ~~2014~~2015 we had fixed the interest rate on $500.0 million of our outstanding Term Loan B Facility. The interest rate on the remaining $164.2 million of our outstanding Term Loan B Facility was variable. Borrowings under our Term Loan B Facility bear interest at a rate equal to an applicable margin plus London Interbank Offered Rate, or LIBOR, with a 1.25% floor, or, at the Company’s option, an applicable margin plus an alternative base rate determined by reference to the higher of the prime rate or the federal funds rate plus 0.5%, with a 2.25% floor. The three-month LIBOR was 0.2627% at ~~December~~March 31, ~~2014~~2015. A hypothetical 1% increase in LIBOR over the 1.25% floor could increase our annual interest expense and related cash flows by approximately $1.6 million based on the unhedged portion of our senior secured credit facilities outstanding as of ~~December~~March 31, ~~2014~~2015.

2930

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As of ~~December~~March 31, ~~2014~~2015, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer (our principal executive officer and principal financial officer, respectively), management evaluated the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15 of the Exchange Act. Based upon this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective, as of the end of the period covered by this quarterly report on Form 10-Q, such that the information relating to us that is required to be disclosed in our reports filed with the SEC (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and (ii) is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Change in Internal Control over Financial Reporting

No change in our internal control over financial reporting occurred during the fiscal quarter ended ~~December~~March 31, ~~2014~~2015 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

3031

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

For information relating to legal proceedings, see Note 7 to the condensed consolidated financial statements contained in Part I, Item 1 of this quarterly report on Form 10-Q.

Item 1A. Risk Factors

There were no material changes from the risk factors disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2014 and filed with the Securities and Exchange Commission on August 8, 2014.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

3132

Item 6. Exhibits



Exhibit No.		Description

31.1	+	Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer

31.2	+	Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer

32.1	+	Certification of the Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350)

32.2	+	Certification of the Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350)



	+	Filed herewith

3233

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the county of Fairfax, Virginia on the ~~6th~~5th day of ~~February~~May, 2015.



	SRA INTERNATIONAL, INC.

	By:		/S/ DAVID F. KEFFER
			David F. Keffer Executive Vice President and Chief Financial Officer (Principal Financial Officer)

3334

Filing Compare · SRA INTERNATIONAL, INC.